Insider Transactions in Q4 2024 at Sema4 Holdings Corp. (SMFR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,728
-11.68%
|
$283,328
$76.75 P/Share
|
|
Dec 16
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,197
+18.39%
|
-
|
|
Dec 16
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,501
-12.86%
|
$798,076
$76.75 P/Share
|
|
Dec 16
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+18.68%
|
-
|
|
Dec 09
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,661
-5.5%
|
$278,236
$76.37 P/Share
|
|
Dec 09
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,547
+8.96%
|
-
|
|
Dec 09
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,137
-4.4%
|
$86,412
$76.37 P/Share
|
|
Dec 09
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,462
+8.69%
|
-
|
|
Dec 02
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
263
-1.11%
|
$20,514
$78.39 P/Share
|
|
Dec 01
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
718
+2.94%
|
-
|
|
Nov 22
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,981
-11.28%
|
$758,556
$76.38 P/Share
|
|
Nov 21
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,019
-4.92%
|
$865,368
$72.34 P/Share
|
|
Nov 20
2024
|
Jason Ryan |
SELL
Open market or private sale
|
Indirect |
15,490
-63.58%
|
$1,068,810
$69.57 P/Share
|
|
Nov 19
2024
|
Jason Ryan |
SELL
Open market or private sale
|
Indirect |
31,510
-25.93%
|
$2,237,210
$71.49 P/Share
|
|
Nov 19
2024
|
Jason Ryan |
SELL
Bona fide gift
|
Indirect |
141,356
-75.05%
|
-
|
|
Nov 18
2024
|
School Of Medicine At Mount Sinai Icahn |
SELL
Open market or private sale
|
Direct |
126,782
-4.45%
|
$8,874,740
$70.78 P/Share
|
|
Nov 18
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,307
-5.05%
|
$1,539,183
$69.4 P/Share
|
|
Nov 15
2024
|
School Of Medicine At Mount Sinai Icahn |
SELL
Open market or private sale
|
Direct |
20,359
-0.71%
|
$1,404,771
$69.78 P/Share
|
|
Nov 15
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,108
-3.44%
|
$1,640,668
$71.65 P/Share
|
|
Oct 31
2024
|
School Of Medicine At Mount Sinai Icahn |
SELL
Open market or private sale
|
Direct |
865,800
-23.2%
|
$64,935,000
$75.0 P/Share
|
|
Oct 29
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,154
-2.0%
|
$142,164
$66.6 P/Share
|
|
Oct 29
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+3.48%
|
-
|
|
Oct 29
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
274
-0.61%
|
$18,084
$66.6 P/Share
|
|
Oct 29
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
753
+1.64%
|
-
|
|
Oct 15
2024
|
Jason Ryan |
BUY
Exercise of conversion of derivative security
|
Direct |
130
+0.18%
|
-
|
|
Oct 15
2024
|
Joshua Ruch |
BUY
Exercise of conversion of derivative security
|
Direct |
130
+1.6%
|
-
|